[go: up one dir, main page]

NO20024095L - Anestetiske formuleringer - Google Patents

Anestetiske formuleringer

Info

Publication number
NO20024095L
NO20024095L NO20024095A NO20024095A NO20024095L NO 20024095 L NO20024095 L NO 20024095L NO 20024095 A NO20024095 A NO 20024095A NO 20024095 A NO20024095 A NO 20024095A NO 20024095 L NO20024095 L NO 20024095L
Authority
NO
Norway
Prior art keywords
anesthetic formulations
propofol
preparations
anesthetic
formulations
Prior art date
Application number
NO20024095A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024095D0 (no
Inventor
James Du Mayne
John Meadows
Original Assignee
Maelor Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maelor Pharmaceuticals Ltd filed Critical Maelor Pharmaceuticals Ltd
Publication of NO20024095D0 publication Critical patent/NO20024095D0/no
Publication of NO20024095L publication Critical patent/NO20024095L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20024095A 2000-02-29 2002-08-28 Anestetiske formuleringer NO20024095L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0004841A GB2359747B (en) 2000-02-29 2000-02-29 Anaesthetic formulations
PCT/GB2001/000868 WO2001064187A2 (fr) 2000-02-29 2001-02-28 Formulations anesthesiques

Publications (2)

Publication Number Publication Date
NO20024095D0 NO20024095D0 (no) 2002-08-28
NO20024095L true NO20024095L (no) 2002-10-23

Family

ID=9886669

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024095A NO20024095L (no) 2000-02-29 2002-08-28 Anestetiske formuleringer

Country Status (21)

Country Link
US (2) US7166303B2 (fr)
EP (1) EP1259226B1 (fr)
JP (1) JP4215430B2 (fr)
KR (1) KR100652552B1 (fr)
CN (1) CN100376232C (fr)
AT (1) ATE324101T1 (fr)
AU (2) AU2001235809B2 (fr)
BR (1) BR0108738A (fr)
CA (1) CA2401089C (fr)
CZ (1) CZ300790B6 (fr)
DE (1) DE60119082T2 (fr)
DK (1) DK1259226T3 (fr)
ES (1) ES2262628T3 (fr)
GB (1) GB2359747B (fr)
HU (1) HU226485B1 (fr)
IL (2) IL151311A0 (fr)
NO (1) NO20024095L (fr)
NZ (1) NZ520765A (fr)
RU (1) RU2250101C2 (fr)
WO (1) WO2001064187A2 (fr)
ZA (1) ZA200206233B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2211151T3 (es) 1998-08-19 2004-07-01 Skyepharma Canada Inc. Dispersiones acuosas inyectables de propofol.
CN1149984C (zh) * 1999-06-21 2004-05-19 健一制药株式会社 用于静脉注射的含有普鲁泊福的麻醉组合物
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations
US6939564B2 (en) * 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
GB0120701D0 (en) * 2001-08-24 2001-10-17 Maelor Pharmaceuticals Ltd Pharmaceutical formulations
GB0120702D0 (en) * 2001-08-24 2001-10-17 Maelor Pharmaceuticals Ltd Anaesthetic formulations
GB0124071D0 (en) * 2001-10-08 2001-11-28 Kbig Ltd Improvement in the administration of high boiling point aneasthetics
IL164217A0 (en) * 2002-04-08 2005-12-18 Guilford Pharm Inc Pharmaceutical compositions containing water-soluble propofol and methods of administering same
US7915317B2 (en) * 2002-07-29 2011-03-29 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
GB0327390D0 (en) * 2003-11-25 2003-12-31 Pfizer Ltd Pharmaceutical formulations
UA85578C2 (ru) * 2004-02-13 2009-02-10 Байоавейлабилити Инк. Микроэмульсионный препарат с высокой концентрацией пропофола для применения в анестезии
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
RU2290169C1 (ru) * 2005-06-23 2006-12-27 Открытое Акционерное Общество "Фаберлик" Косметическое и/или дерматологическое средство и антиоксидант
CA2657090C (fr) * 2005-07-08 2013-09-03 Physica Pharma Microemulsion pharmaceutique aqueuse et transparente comprenant du propofol, et son procede de preparation
US8546329B2 (en) * 2006-03-22 2013-10-01 Chugai Seiyaku Kabushiki Kaisha Erythropoietin solution preparation
CN100579510C (zh) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 新型前体胶束制剂及其生产方法
MX2009003092A (es) * 2006-09-22 2009-05-08 Labopharm Inc Composiciones y metodos para suministro de farmaco dirigido a ph.
KR20080102010A (ko) * 2007-05-17 2008-11-24 대원제약주식회사 프로포폴을 포함하는 주사제용 조성물 및 이의 제조 방법
WO2010088924A1 (fr) * 2009-02-06 2010-08-12 Telormedix Sa Compositions pharmaceutiques comprenant des imidazoquinolines (amines) et des dérivés de celles-ci appropriés pour une administration locale
US8945627B2 (en) * 2011-05-05 2015-02-03 Wisconsin Alumni Research Foundation Micelles for the solubilization of gossypol
RU2535001C1 (ru) * 2013-07-11 2014-12-10 Общество с ограниченной ответственностью "ВИК-здоровье животных" Микроколлоидный раствор пропофола для анестезии
EP3164111B1 (fr) 2014-07-02 2019-04-03 The Research Foundation for the State University of New York Compositions de micelles dépouillées d'agent tensioactif à rapport élevé entre charge et agent tensioactif

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
DE4039602A1 (de) * 1990-12-12 1992-06-17 Bauer Kurt Heinz Prof Dr Pharmazeutische formulierungen
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
GB9405593D0 (en) 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US5635536A (en) * 1994-12-07 1997-06-03 Pharmacia & Upjohn Aktiebolag Emulsion suitable for administering a sphingolipid
RU2104053C1 (ru) * 1995-05-26 1998-02-10 Новокузнецкий филиал Научно-исследовательского института общей реаниматологии АМН РФ Способ общей анестезии при экстренных оперативных вмешательствах у больных с травматическим шоком
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
ES2211151T3 (es) * 1998-08-19 2004-07-01 Skyepharma Canada Inc. Dispersiones acuosas inyectables de propofol.
CN1149984C (zh) * 1999-06-21 2004-05-19 健一制药株式会社 用于静脉注射的含有普鲁泊福的麻醉组合物
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations

Also Published As

Publication number Publication date
US7166303B2 (en) 2007-01-23
EP1259226B1 (fr) 2006-04-26
US20030138489A1 (en) 2003-07-24
CN100376232C (zh) 2008-03-26
CZ300790B6 (cs) 2009-08-12
EP1259226A2 (fr) 2002-11-27
ATE324101T1 (de) 2006-05-15
HU226485B1 (en) 2009-03-02
IL151311A (en) 2007-10-31
CN1416337A (zh) 2003-05-07
RU2250101C2 (ru) 2005-04-20
GB2359747B (en) 2002-04-24
AU3580901A (en) 2001-09-12
KR100652552B1 (ko) 2006-11-30
WO2001064187A2 (fr) 2001-09-07
JP2003525231A (ja) 2003-08-26
DK1259226T3 (da) 2006-08-21
HUP0300125A2 (hu) 2003-07-28
CA2401089A1 (fr) 2001-09-07
HUP0300125A3 (en) 2003-09-29
NO20024095D0 (no) 2002-08-28
DE60119082T2 (de) 2006-11-30
BR0108738A (pt) 2002-12-17
AU2001235809B2 (en) 2004-08-05
DE60119082D1 (de) 2006-06-01
GB2359747A (en) 2001-09-05
CA2401089C (fr) 2011-01-18
RU2002123180A (ru) 2004-03-20
CZ20022914A3 (cs) 2003-01-15
IL151311A0 (en) 2003-04-10
WO2001064187A3 (fr) 2002-01-03
US20070122467A1 (en) 2007-05-31
WO2001064187A8 (fr) 2002-10-03
KR20030011781A (ko) 2003-02-11
WO2001064187B1 (fr) 2002-03-07
GB0004841D0 (en) 2000-04-19
NZ520765A (en) 2003-07-25
JP4215430B2 (ja) 2009-01-28
ZA200206233B (en) 2003-11-05
ES2262628T3 (es) 2006-12-01

Similar Documents

Publication Publication Date Title
DK1259226T3 (da) Anæstetiske formuleringer
CR7614A (es) Preparaciones de insulina acida con estabilidad mejorada
DE60224284D1 (de) Stabile formulierung von modifiziertem glp-1
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
ATE415943T1 (de) Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoff
DK0666736T3 (da) Stabilisering af fluorcarbon-emulsioner
ATE218364T1 (de) Stabile konzentrierte insulin präparationen zur pulmonaren verabreichung
DE69521693D1 (de) Taxanderivate enthaltende arzneizubereitungen
DE69629989D1 (de) Präparate zur äusserlichen anwendung zur behandlung von dermatosen
SE9800729L (sv) Ny topikal formulering I
EE9900612A (et) Inimese papilloomiviiruse stabiliseeritud preparaadid
NO20043001D0 (no) Farmasoytisk formulering omfattende cyklosporin og anvendelse derav
DE60207266D1 (de) Anaesthetische propofol zubereitungen
ATE380543T1 (de) Stabilisierung von festen schilddrüsenhormonzusammensetzungen
NZ521533A (en) Veterinary compositions for the treatment of parasitic diseases containing rafoxanide
DE60135845D1 (de) Pralmorelin-haltige nasentropfen-präparate
ATE301453T1 (de) Injizierbare arzneiformulierungen von partricin derivaten
DE60141632D1 (de) Zusammensetzung zur stabilisierung von fettlöslichen vitaminen in wässeriger lösung
RU97113620A (ru) Ранозаживляющая мазь "эпофен"
CL2015003413A1 (es) Formulación estable que comprende la proteína iduronato-2-sulfatasa y un tensoactico de polisorbato; contenedor que comprende dicha formulación; uso de dicha formulación para tratar síndrome de hunters.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application